These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 21710471

  • 1. Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents--a potentially lethal cocktail.
    Charlton M.
    Hepatology; 2011 Jul; 54(1):3-5. PubMed ID: 21710471
    [No Abstract] [Full Text] [Related]

  • 2. Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus.
    Garg V, van Heeswijk R, Lee JE, Alves K, Nadkarni P, Luo X.
    Hepatology; 2011 Jul; 54(1):20-7. PubMed ID: 21618566
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers.
    Hulskotte E, Gupta S, Xuan F, van Zutven M, O'Mara E, Feng HP, Wagner J, Butterton J.
    Hepatology; 2012 Nov; 56(5):1622-30. PubMed ID: 22576324
    [Abstract] [Full Text] [Related]

  • 4. Pharmacodynamic monitoring of immunosuppressive effects indicates reduced cyclosporine activity during telaprevir therapy.
    Roos K, Gotthardt D, Giese T, Schnitzler P, Stremmel W, Czock D, Eisenbach C.
    Liver Transpl; 2014 Sep; 20(9):1106-17. PubMed ID: 24890314
    [Abstract] [Full Text] [Related]

  • 5. [Boceprevir and telaprevir: clinical efficacy, safety and drug-drug interactions].
    Nikitin AV.
    Antibiot Khimioter; 2012 Sep; 57(9-10):47-9. PubMed ID: 23477220
    [No Abstract] [Full Text] [Related]

  • 6. [Drug-drug interaction with telaprevir or boceprevir in liver transplant patients: about four cases].
    Delaborde L, Logerot S, Fonrose X.
    Therapie; 2014 Sep; 69(6):491-7. PubMed ID: 25320939
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Directly acting antivirals for hepatitis C and antiretrovirals: potential for drug-drug interactions.
    Seden K, Back D.
    Curr Opin HIV AIDS; 2011 Nov; 6(6):514-26. PubMed ID: 22001895
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Drug-drug interactions with oral anti-HCV agents and idiosyncratic hepatotoxicity in the liver transplant setting.
    Tischer S, Fontana RJ.
    J Hepatol; 2014 Apr; 60(4):872-84. PubMed ID: 24280292
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Interaction between tacrolimus and omeprazole in a pediatric liver transplant recipient.
    Moreau C, Debray D, Loriot MA, Taburet AM, Furlan V.
    Transplantation; 2006 Feb 15; 81(3):487-8. PubMed ID: 16477241
    [No Abstract] [Full Text] [Related]

  • 17. Viral hepatitis: Ciclosporin versus tacrolimus for HCV transplant recipients.
    Berenguer M.
    Nat Rev Gastroenterol Hepatol; 2011 Jul 12; 8(8):422-4. PubMed ID: 21750517
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Successful reconversion from tacrolimus to cyclosporine A Neoral in pediatric liver recipients.
    Melter M, Rodeck B, Kardorff R, Hoyer PF, Maibücher A, Brodehl J.
    Transplant Proc; 1996 Aug 12; 28(4):2276-8. PubMed ID: 8769224
    [No Abstract] [Full Text] [Related]

  • 20. [New times for the treatment of chronic hepatitis C].
    Gerstoft J, Fomsgaard A.
    Ugeskr Laeger; 2012 Mar 19; 174(12):795. PubMed ID: 22433552
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.